Wird geladen...
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
Outcomes of patients with multiple myeloma (MM) who become refractory to standard therapies are particularly poor and novel agents are greatly needed to improve outcomes in such patients. B-cell maturation antigen (BCMA) has become an important therapeutic target in MM with three modalities of treat...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Hematol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7970693/ https://ncbi.nlm.nih.gov/pubmed/33796236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620721989585 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|